(Q37477083)

20 August 2017

Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey (English)

1 reference

20 August 2017

0 references

1 reference

1 reference

Peter Gibbs

7

0 references

Michael Jefford

object named as

Michael Jefford

3

0 references

author name string

Kathryn M Field

1

1 reference

20 August 2017

Suzanne Kosmider

2

1 reference

20 August 2017

Michael Michael

4

1 reference

20 August 2017

Ross Jennens

5

1 reference

20 August 2017

Michael Green

6

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

Journal of Oncology Practice

20 August 2017

1 reference

20 August 2017

4

1 reference

20 August 2017

3

1 reference

20 August 2017

108-113

1 reference

The impact of obesity on the incidence and treatment of gynecologic cancers: a review

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

The use of body surface area as a criterion of drug dosage in cancer chemotherapy.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Prescribing anti-cancer drugs in elderly cancer patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Impact of body-size measures on irinotecan clearance: alternative dosing recommendations

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Body surface area as a determinant of pharmacokinetics and drug dosing

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

A practical approach to the older patient with cancer.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

The impact of chemotherapy dose density and dose intensity on breast cancer outcome: what have we learned?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

The use of the Calvert formula to determine the optimal carboplatin dosage

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Comorbidity and functional status are independent in older cancer patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Variability in determination of body weight used for dosing busulphan and cyclophosphamide in adult patients: results of an international survey

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Neutropenia-wise and pound-foolish: safe and effective chemotherapy in massively obese patients

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

A standard weight descriptor for dose adjustment in the obese patient

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Implications of dose rounding of chemotherapy to the nearest vial size

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Obesity and therapy-related toxicity in patients treated for small-cell lung cancer.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794002

Developing a new framework for dose calculation

2 October 2018

1 reference

12 December 2020

Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance

1 reference

12 December 2020

Undertreatment of obese women receiving breast cancer chemotherapy

1 reference

12 December 2020

Is pharmacokinetically guided chemotherapy dosage a better way forward?

1 reference

12 December 2020

Obesity and dose individualization in cancer chemotherapy: the role of body surface area and body mass index

1 reference

12 December 2020

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

12 December 2020

Management of cancer in the older person: a practical approach

1 reference

12 December 2020

Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer

1 reference

12 December 2020

Obesity at Diagnosis of Breast Carcinoma Influences Duration of Disease-free Survival

1 reference

12 December 2020

Can we individualize chemotherapy for colorectal cancer?

1 reference

12 December 2020

Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B

1 reference

12 December 2020

Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation

1 reference

12 December 2020

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541

1 reference

12 December 2020

Identifiers

DOI

10.1200/JOP.0832001

1 reference

20 August 2017

1 reference

20 August 2017

1 reference